A new sampling technology developed by a partnership between Life Science Group Ltd of Bedford, and the University of Bedfordshire, has the potential to transform the global battle against Coronavirus (Sars-CoV-2) and other viruses by improving the speed and safety of sampling, whilst maintaining the quality of the viral sample. Public Health England have just formally validated the approach, confirming that the new testing buffer the team has developed does inactivate the virus, making the samples non-infectious and safe to handle. Read the full article here.